FDA — authorised 9 March 1960
- Application: NDA012265
- Marketing authorisation holder: SCHERING
- Local brand name: NAQUA
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 TRICHLORMETHIAZIDE in United States
FDA authorised TRICHLORMETHIAZIDE on 9 March 1960
Marketing authorisations
FDA — authorised 16 May 1977
- Application: ANDA085630
- Marketing authorisation holder: LANNETT
- Local brand name: TRICHLOREX
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 5 October 1977
- Application: ANDA085568
- Marketing authorisation holder: CHARTWELL RX
- Local brand name: TRICHLORMETHIAZIDE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 31 October 1978
- Application: ANDA086458
- Marketing authorisation holder: WATSON LABS
- Local brand name: TRICHLORMETHIAZIDE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 11 August 1980
- Application: ANDA083436
- Marketing authorisation holder: LANNETT
- Local brand name: TRICHLOREX
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 21 July 1982
- Application: ANDA086171
- Marketing authorisation holder: SANDOZ
- Local brand name: TRICHLORMETHIAZIDE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 16 June 1988
- Application: NDA012594
- Marketing authorisation holder: SANOFI AVENTIS US
- Local brand name: METAHYDRIN
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA083462
- Marketing authorisation holder: WATSON LABS
- Local brand name: TRICHLORMETHIAZIDE
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA083967
- Marketing authorisation holder: IMPAX LABS
- Local brand name: TRICHLORMETHIAZIDE
- Indication: TABLET — ORAL
- Status: approved
FDA
- Status: approved
FDA
- Application: ANDA085962
- Marketing authorisation holder: WATSON LABS
- Local brand name: TRICHLORMETHIAZIDE
- Indication: TABLET — ORAL
- Status: approved
TRICHLORMETHIAZIDE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is TRICHLORMETHIAZIDE approved in United States?
Yes. FDA authorised it on 9 March 1960; FDA authorised it on 16 May 1977; FDA authorised it on 5 October 1977.
Who is the marketing authorisation holder for TRICHLORMETHIAZIDE in United States?
SCHERING holds the US marketing authorisation.